How can I manage appetite suppression caused by Vyvanse (lisdexamfetamine)?

Managing Appetite Suppression from Vyvanse

The most effective strategy is to take Vyvanse with meals and provide high-calorie snacks or drinks in the late evening when medication effects have worn off, while monitoring weight regularly to ensure the appetite suppression doesn't lead to clinically significant weight loss. 1

Immediate Management Strategies

Timing and Meal Planning

• Administer Vyvanse with breakfast or meals to maximize food intake during the dosing period 1
• Provide calorie-dense foods and beverages in the late evening (after 6-8 PM) when stimulant effects have diminished and natural appetite returns 1
• Focus on nutrient-dense, high-calorie options during this rebound window when the patient is more likely to eat

Monitoring Requirements

• Weigh the patient at each visit to objectively track appetite suppression impact 1
• Weight checks provide concrete data on whether the appetite loss is causing clinically meaningful problems
• Small weight decrements during short-term treatment are common and typically not clinically significant 1

When to Adjust Treatment

Dose Modification

If weight loss becomes concerning or appetite suppression is severe:

• Reduce the Vyvanse dose 1
• Consider whether the current dose is necessary for symptom control—sometimes lower doses provide adequate ADHD management with fewer side effects
• The FDA label confirms decreased appetite occurs in a significant proportion of patients, with weight loss being a common side effect 2

Medication Switching

If appetite suppression persists despite dose reduction and timing strategies:

• Consider switching to atomoxetine or alpha-2 agonists (guanfacine, clonidine), which have different side effect profiles and don't typically cause the same degree of appetite suppression 3
• These non-stimulant options may be preferable if appetite loss significantly impacts quality of life or growth

Important Clinical Considerations

Growth Monitoring in Children

• Long-term growth delays are not typically clinically significant in prospective follow-up studies into adulthood 1
• However, monitor height and weight regularly during treatment, especially in children
• The MTA study showed decrements in weight acquisition rates but minimal impact on height during 14-month treatment 1

Common Pitfalls to Avoid

• Don't immediately discontinue effective treatment for mild appetite changes—implement dietary strategies first
• Don't ignore progressive weight loss—this requires dose adjustment or medication change 1
• Don't assume appetite will normalize on its own—this is a dose-dependent side effect that typically persists throughout treatment 2, 4

Expected Timeline

• Appetite suppression typically begins within 1-2 hours of dosing and lasts up to 13 hours 5
• The effect is most pronounced during peak medication levels (mid-day)
• Natural appetite often returns in the evening, creating an optimal window for caloric intake

Evidence Quality Note

The management strategies come from established clinical practice guidelines from the American Academy of Child and Adolescent Psychiatry 1, which provide the strongest evidence base for managing stimulant-related appetite suppression. The FDA label 2 confirms decreased appetite as one of the most common side effects, occurring frequently enough to warrant systematic monitoring. Recent research 4, 6 confirms this side effect profile remains consistent across populations.